PHASE-I AND PHARMACOLOGICAL STUDY OF ACIVICIN BY 24-HOUR CONTINUOUS INFUSION

被引：0
|
作者：
WEISS, GR
MCGOVREN, JP
SCHADE, D
KUFE, DW
机构：
[1] HARVARD UNIV, SCH MED, SIDNEY FARBER CANC INST, DIV MED, BOSTON, MA 02115 USA
[2] UPJOHN CO, KALAMAZOO, MI 49001 USA
来源：
CANCER RESEARCH | 1982年 / 42卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3892 / 3895
页数：4
相关论文
共 50 条
  • [1] PHASE-I STUDY OF PENTAMETHYLMELAMINE (PMM) BY 24-HOUR INFUSION
    CASPER, ES
    ALCOCK, NW
    KELSEN, DP
    YOUNG, CW
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 178 - 178
  • [2] PHASE-I PHARMACOKINETIC STUDY OF TOPOTECAN BY 24-HOUR CONTINUOUS-INFUSION WEEKLY
    HAAS, NB
    LACRETA, FP
    WALCZAK, J
    HUDES, GR
    BRENNAN, JM
    OZOLS, RF
    ODWYER, PJ
    CANCER RESEARCH, 1994, 54 (05) : 1220 - 1226
  • [3] PHASE-I STUDY OF ADOZELESIN ADMINISTERED BY 24-HOUR CONTINUOUS INTRAVENOUS-INFUSION
    FLEMING, GF
    RATAIN, MJ
    OBRIEN, SM
    SCHILSKY, RL
    HOFFMAN, PC
    RICHARDS, JM
    VOGELZANG, NJ
    KASUNIC, DA
    EARHART, RH
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (05) : 368 - 372
  • [4] PHASE-I CLINICAL-TRIAL OF FAZARABINE AS A 24-HOUR CONTINUOUS INFUSION
    BAILEY, H
    TUTSCH, KD
    ARZOOMANIAN, RZ
    TOMBES, MB
    ALBERTI, D
    BRUGGINK, J
    WILDING, G
    CANCER RESEARCH, 1991, 51 (04) : 1105 - 1108
  • [5] PEDIATRIC PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF TOPOTECAN ADMINISTERED AS A 24-HOUR CONTINUOUS INFUSION
    BLANEY, SM
    BALIS, FM
    COLE, DE
    CRAIG, C
    REID, JM
    AMES, MM
    KRAILO, M
    REAMAN, G
    HAMMOND, D
    POPLACK, DG
    CANCER RESEARCH, 1993, 53 (05) : 1032 - 1036
  • [6] PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF TOPOTECAN ADMINISTERED BY A 24-HOUR CONTINUOUS-INFUSION
    VANWARMERDAM, LJC
    HUININK, WWB
    RODENHUIS, S
    KOIER, I
    DAVIES, BE
    ROSING, H
    MAES, RAA
    BEIJNEN, JH
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (07) : 1768 - 1776
  • [7] PHASE-I AND PHARMACOKINETIC STUDY OF PACLITAXEL BY 24-HOUR INTRAVENOUS-INFUSION
    TAMURA, T
    SASAKI, Y
    EGUCHI, K
    SHINKAI, T
    OHE, Y
    NISHIO, M
    KUNIKANE, H
    ARIOKA, H
    KARATO, A
    OMATSU, H
    NAKASHIMA, H
    SAIJO, N
    JAPANESE JOURNAL OF CANCER RESEARCH, 1994, 85 (10): : 1057 - 1062
  • [8] PHASE-I STUDY OF WEEKLY MAYTANSINE GIVEN BY IV BOLUS OR 24-HOUR INFUSION
    CHAHINIAN, AP
    NOGEIRE, C
    OHNUMA, T
    GREENBERG, ML
    SIVAK, M
    JAFFREY, IS
    HOLLAND, JF
    CANCER TREATMENT REPORTS, 1979, 63 (11-1): : 1953 - 1960
  • [9] PHASE-I STUDY OF 24-HOUR CONTINUOUS INTRAVENOUS-INFUSION OF RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR
    STEINMETZ, T
    SCHAADT, M
    GAHL, R
    SCHENK, V
    DIEHL, V
    PFREUNDSCHUH, M
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1988, 7 (05): : 417 - 423
  • [10] PHASE-I TRIAL OF 5-FLUOROURACIL BY 24-HOUR INFUSION WEEKLY
    HAAS, NB
    HINES, JB
    HUDES, GR
    JOHNSTON, N
    OZOLS, RF
    ODWYER, PJ
    INVESTIGATIONAL NEW DRUGS, 1993, 11 (2-3) : 181 - 185
12345